BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shivangi, Meena LS. A Novel Approach in Treatment of Tuberculosis by Targeting Drugs to Infected Macrophages Using Biodegradable Nanoparticles. Appl Biochem Biotechnol 2018;185:815-21. [DOI: 10.1007/s12010-018-2695-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Rojo L, García-Fernández L, Aguilar MR, Vázquez-Lasa B. Antimicrobial polymeric biomaterials based on synthetic, nanotechnology, and biotechnological approaches. Curr Opin Biotechnol 2022;76:102752. [PMID: 35809432 DOI: 10.1016/j.copbio.2022.102752] [Reference Citation Analysis]
2 Anali Bazán Henostroza M, Diniz Tavares G, Nishitani Yukuyama M, De Souza A, José Barbosa E, Carlos Avino V, Dos Santos Neto E, Rebello Lourenço F, Löbenberg R, Araci Bou-Chacra N. Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection. Int J Pharm 2022;:121782. [PMID: 35489605 DOI: 10.1016/j.ijpharm.2022.121782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Song Q, Bian Q, Liang T, Zhang Y, Zhang K. Identification of immune-related genes and susceptible population of pulmonary tuberculosis by constructing TF-miRNA-mRNA regulatory network. Tuberculosis (Edinb) 2021;131:102139. [PMID: 34740018 DOI: 10.1016/j.tube.2021.102139] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Torres Andón F, Bondarenko O. Recent Discoveries in Nanoparticle-Macrophage Interactions: In Vitro Models for Nanosafety Testing and Novel Nanomedical Approaches for Immunotherapy. Nanomaterials (Basel) 2021;11:2971. [PMID: 34835734 DOI: 10.3390/nano11112971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nabi B, Rehman S, Aggarwal S, Baboota S, Ali J. Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention. Drug Deliv Transl Res 2020;10:1111-21. [PMID: 32418158 DOI: 10.1007/s13346-020-00786-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Noh MAA, Fazalul Rahiman SS, A Wahab H, Mohd Gazzali A. Discovery of new targeting agents against GAPDH receptor for antituberculosis drug delivery. J Basic Clin Physiol Pharmacol 2021;32:715-22. [PMID: 34214294 DOI: 10.1515/jbcpp-2020-0435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hetzel M, Ackermann M, Lachmann N. Beyond "Big Eaters": The Versatile Role of Alveolar Macrophages in Health and Disease. Int J Mol Sci 2021;22:3308. [PMID: 33804918 DOI: 10.3390/ijms22073308] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Liang Q, Xiang H, Li X, Luo C, Ma X, Zhao W, Chen J, Tian Z, Li X, Song X. Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice. Int J Nanomedicine 2020;15:7491-507. [PMID: 33116484 DOI: 10.2147/IJN.S257758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pai S, Muruganandah V, Kupz A. What lies beneath the airway mucosal barrier? Throwing the spotlight on antigen-presenting cell function in the lower respiratory tract. Clin Transl Immunology 2020;9:e1158. [PMID: 32714552 DOI: 10.1002/cti2.1158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Shivangi, Beg MA, Meena LS. Mutational effects on structural stability of SRP pathway dependent co-translational protein ftsY of Mycobacterium tuberculosis H37Rv. Gene Reports 2019;15:100395. [DOI: 10.1016/j.genrep.2019.100395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Churilov L, Korzhikov-Vlakh V, Sinitsyna E, Polyakov D, Darashkevich O, Poida M, Platonova G, Vinogradova T, Utekhin V, Zabolotnykh N, Zinserling V, Yablonsky P, Urtti A, Tennikova T. Enhanced Delivery of 4-Thioureidoiminomethylpyridinium Perchlorate in Tuberculosis Models with IgG Functionalized Poly(Lactic Acid)-Based Particles. Pharmaceutics 2018;11:E2. [PMID: 30577686 DOI: 10.3390/pharmaceutics11010002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Dua K, Rapalli VK, Shukla SD, Singhvi G, Shastri MD, Chellappan DK, Satija S, Mehta M, Gulati M, Pinto TDJA, Gupta G, Hansbro PM. Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches. Biomedicine & Pharmacotherapy 2018;107:1218-29. [DOI: 10.1016/j.biopha.2018.08.101] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 10.5] [Reference Citation Analysis]